Justin Dye - Nov 14, 2022 Form 4/A Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role: Director, 10%+ Owner
Signature: /s/ Daniel R. Pabon Attorney-in-Fact for Justin C. Dye
Stock symbol: SHWZ
Transactions as of: Nov 14, 2022
Transactions value $: $1,061,620
Form type: 4/A
Date filed: 2/15/2024, 06:37 PM
Date Of Original Report: Nov 16, 2022
Previous filing: Apr 8, 2022
Next filing: Nov 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHWZ	Common Stock	Award	$312K	+198K	+68.22%	$1.57	489K	Nov 15, 2022	Direct	F1, F2
transaction	SHWZ	Common Stock	Purchase	$750K	+500K		$1.50	500K	Feb 13, 2023	See footnote	F3
transaction	SHWZ	Common Stock	Award	$0	+131K	+8.8%	$0.00	1.62M	Sep 29, 2023	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 14, 2022, the reporting person filed a Form 4 that erroneously reported a purchase of 187,484 of shares of Common Stock on November 15, 2022. In fact, as reported in this amendment, the purchase made on November 15, 2022, involved 198,484 shares of common stock. This filing properly reflects the correct number of shares acquired and beneficially owned by the reporting person in and following the reported transaction.
F2	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price within the range set forth in this footnote.
F3	On February 15, 2023, the reporting person filed a Form 4 that erroneously reported a purchase of 500,000 of Common Stock on February 13, 2023, as directly owned by the reporting person. In fact, as reported in this amendment, the purchase made on February 13, 2024, represents shares of common stock held by Dye Capital LLLP ("Dye LLLP"). As the managing partner of Dye LLLP, Mr. Dye has voting and investment control over the securities held by Dye LLLP. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. This filing properly reflects the correct number of shares acquired and beneficially owned by the reporting person in and following the reported transaction.
F4	The issuer granted the reporting person shares of common stock with an aggregate value of $103,333 (based on the closing price of the common stock on the OTCQX Best Market on September 29, 2023) for services on the board of directors.
F5	On October 6, 2023, the reporting person filed a Form 4 that erroneously reported the Amount of Securities Beneficially Owned Following Reported Transaction of 1,998,863 shares of Common Stock directly owned by the reporting person. In fact, as reported in this amendment, the Amount of Securities Beneficially Owned Following Reported Transaction involved 1,616,363 shares of Common Stock. This filing properly reflects the correct number of shares acquired and beneficially owned, directly, by the reporting person in and following the reported transaction.